APPE RISEsm invites you to submit a proposal for its annual symposium that explores the definition, scope and impact of engagement among researchers, institutions, communities and the public, with a view to foster discussions about the complex nature of engagement. Read more
We are finally witnessing increasing adoption of digital pathology in clinical practice. Pathologists are beginning to embrace and utilize artificial intelligence (AI) tools and ideas to augment routine pathology practice. All stakeholders in pathology need to fully understand the ethical frameworks required to develop, deploy, and maintain transparent, trustworthy, explainable, scalable, interoperable, and sustainable digital AI tools. Read more
The clinical trial workforce's incredible response to the COVID-19 pandemic has generated some of the most positive media coverage and public acclaim the drug and device research and development industry has ever seen. "We need to harness that public awareness," says Elisa Hurley, PhD, executive director of PRIM&R. Read more
What makes feedback on a proposed NIH policies useful? How can you be more effective in shaping biomedical research policy? Get the insider's guide from NIH Associate Director for Science Policy Carrie D. Wolinetz, PhD, in this cross-post from Under the Poliscope. Read more
Imagine this scenario: you are a researcher conducting a clinical trial on a promising treatment for a rare but serious heart condition. Unfortunately, you are struggling to locate and enroll enough eligible participants and your study is at risk of not completing. Then you discover a Facebook support group for precisely the condition you are studying. The group is open: you do not need to be invited or to suffer from the condition to become a member—anyone can join. Here are the eligible participants you have been looking for! Read more
